{
  "description": null,
  "compose": {
    "include": [ {
      "valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1254" ]
    } ]
  },
  "_filename": "ValueSet-2.16.840.1.113883.3.464.1003.1050.json",
  "package_name": "us.nlm.vsac",
  "date": "2024-01-23T01:10:32-05:00",
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
    "versionId": "16",
    "lastUpdated": "2024-01-24T09:18:12.000-05:00"
  },
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [ {
    "coding": [ {
      "code": "US",
      "system": "urn:iso:std:iso:3166"
    } ]
  } ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Gastrointestinal Antispasmodics for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes atropine, chlordiazepoxide-clidinium, dicyclomine, hyoscyamine, and scopolamine. Includes concepts that represent generic, human use and prescribable medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes ophthalmic routes.)",
  "name": "PotentiallyHarmfulGastrointestinalAntispasmodicsForOlderAdults",
  "type": null,
  "experimental": null,
  "resourceType": "ValueSet",
  "expansion": {
    "total": 41,
    "contains": [ {
      "code": "1037234",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1046770",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1046787",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution",
      "version": "11042024"
    }, {
      "code": "1046815",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1046982",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.125 MG Sublingual Tablet",
      "version": "11042024"
    }, {
      "code": "1046985",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1046997",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1047786",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1047881",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.025 MG/ML Oral Solution",
      "version": "11042024"
    }, {
      "code": "1047895",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.125 MG/ML Oral Solution",
      "version": "11042024"
    }, {
      "code": "1047905",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.125 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1047916",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "1 ML hyoscyamine sulfate 0.5 MG/ML Injection",
      "version": "11042024"
    }, {
      "code": "1048124",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1048307",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule",
      "version": "11042024"
    }, {
      "code": "1048336",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1050325",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1087365",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule",
      "version": "11042024"
    }, {
      "code": "1190538",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "0.7 ML atropine sulfate 0.714 MG/ML Auto-Injector",
      "version": "11042024"
    }, {
      "code": "1190540",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "0.7 ML atropine sulfate 1.43 MG/ML Auto-Injector",
      "version": "11042024"
    }, {
      "code": "1190542",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "0.7 ML atropine sulfate 2.86 MG/ML Auto-Injector",
      "version": "11042024"
    }, {
      "code": "1190546",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "10 ML atropine sulfate 0.1 MG/ML Prefilled Syringe",
      "version": "11042024"
    }, {
      "code": "1190551",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "5 ML atropine sulfate 0.05 MG/ML Prefilled Syringe",
      "version": "11042024"
    }, {
      "code": "1190552",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "5 ML atropine sulfate 0.1 MG/ML Prefilled Syringe",
      "version": "11042024"
    }, {
      "code": "1190568",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution",
      "version": "11042024"
    }, {
      "code": "1190572",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1190738",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1190748",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "5 ML atropine sulfate 0.14 MG/ML / edrophonium chloride 10 MG/ML Injection",
      "version": "11042024"
    }, {
      "code": "1190776",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.4 MG/ML Injectable Solution",
      "version": "11042024"
    }, {
      "code": "1190795",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "1 ML atropine sulfate 1 MG/ML Injection",
      "version": "11042024"
    }, {
      "code": "1440869",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "1666781",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "1 ML atropine sulfate 0.4 MG/ML Injection",
      "version": "11042024"
    }, {
      "code": "1807886",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet",
      "version": "11042024"
    }, {
      "code": "226552",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "72 HR scopolamine 0.0139 MG/HR Transdermal System",
      "version": "11042024"
    }, {
      "code": "2637557",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule",
      "version": "11042024"
    }, {
      "code": "727415",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector",
      "version": "11042024"
    }, {
      "code": "889614",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule",
      "version": "11042024"
    }, {
      "code": "991061",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "dicyclomine hydrochloride 10 MG Oral Capsule",
      "version": "11042024"
    }, {
      "code": "991065",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "2 ML dicyclomine hydrochloride 10 MG/ML Injection",
      "version": "11042024"
    }, {
      "code": "991082",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "dicyclomine hydrochloride 2 MG/ML Oral Solution",
      "version": "11042024"
    }, {
      "code": "991086",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "dicyclomine hydrochloride 20 MG Oral Tablet",
      "version": "11042024"
    }, {
      "code": "998726",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule",
      "version": "11042024"
    } ],
    "timestamp": "2024-12-10T10:30:45-05:00",
    "identifier": "urn:uuid:68f9057f-ea1d-4cd2-bd98-f980f97b9477"
  },
  "title": "Potentially Harmful Gastrointestinal Antispasmodics for Older Adults",
  "package_version": "0.21.0",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueContactDetail": {
      "name": "NCQA PHEMUR Author"
    }
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2024-01-23"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2024-01-23"
  } ],
  "status": "active",
  "id": "337b33fd-60f7-4c20-9b17-674befb22e03",
  "kind": null,
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1050",
  "identifier": [ {
    "value": "urn:oid:2.16.840.1.113883.3.464.1003.1050",
    "system": "urn:ietf:rfc:3986"
  } ],
  "version": "20240123"
}